Edwin C. Hendrick

US Pathology Labs, Inc. operates anatomic pathology laboratories. The firm offers diagnosis, prognosis, genomics, and genetic testing services to hospitals, physician offices, surgery centers, and biopharmaceutical companies. The company was founded in 1997 and is headquartered in Irvine, CA.

PLUS Diagnostics, Inc. provides comprehensive pathology services. The firm specializes in genitourinary and gastrointestinal pathology, breast pathology, dermatopathology, hematopathology, oral and maxillofacial pathology. The company was founded in 1990 and is headquartered in Union, NJ.

Esoterix, Inc. provides laboratory testing services. The company performs esoteric laboratory tests including testing for asthma, bleeding disorders, cancer, diabetes, and infectious diseases. The company was founded in 1995 and is headquartered in Austin, TX.

Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ.

Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA.

Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in New York, NY.

Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA.